In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review

This review highlights in vitro drug dissolution/permeation methods available for topical and transdermal nanocarriers that have been designed to modulate the propensity of drug release, drug penetration into skin, and permeation into systemic circulation. Presently, a few of USFDA-approved in vitro...

Full description

Bibliographic Details
Published in:AAPS PharmSciTech
Main Author: 2-s2.0-85064531332
Format: Review
Language:English
Published: Springer New York LLC 2019
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064531332&doi=10.1208%2fs12249-019-1362-7&partnerID=40&md5=670898e9a34f95aea122bb4030a8b478
id Sheshala R.; Anuar N.K.; Abu Samah N.H.; Wong T.W.
spelling Sheshala R.; Anuar N.K.; Abu Samah N.H.; Wong T.W.
2-s2.0-85064531332
In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review
2019
AAPS PharmSciTech
20
5
10.1208/s12249-019-1362-7
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064531332&doi=10.1208%2fs12249-019-1362-7&partnerID=40&md5=670898e9a34f95aea122bb4030a8b478
This review highlights in vitro drug dissolution/permeation methods available for topical and transdermal nanocarriers that have been designed to modulate the propensity of drug release, drug penetration into skin, and permeation into systemic circulation. Presently, a few of USFDA-approved in vitro dissolution/permeation methods are available for skin product testing with no specific application to nanocarriers. Researchers are largely utilizing the in-house dissolution/permeation testing methods of nanocarriers. These drug release and permeation methods are pending to be standardized. Their biorelevance with reference to in vivo plasma concentration–time profiles requires further exploration to enable translation of in vitro data for in vivo or clinical performance prediction. © 2019, American Association of Pharmaceutical Scientists.
Springer New York LLC
15309932
English
Review

author 2-s2.0-85064531332
spellingShingle 2-s2.0-85064531332
In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review
author_facet 2-s2.0-85064531332
author_sort 2-s2.0-85064531332
title In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review
title_short In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review
title_full In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review
title_fullStr In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review
title_full_unstemmed In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review
title_sort In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review
publishDate 2019
container_title AAPS PharmSciTech
container_volume 20
container_issue 5
doi_str_mv 10.1208/s12249-019-1362-7
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064531332&doi=10.1208%2fs12249-019-1362-7&partnerID=40&md5=670898e9a34f95aea122bb4030a8b478
description This review highlights in vitro drug dissolution/permeation methods available for topical and transdermal nanocarriers that have been designed to modulate the propensity of drug release, drug penetration into skin, and permeation into systemic circulation. Presently, a few of USFDA-approved in vitro dissolution/permeation methods are available for skin product testing with no specific application to nanocarriers. Researchers are largely utilizing the in-house dissolution/permeation testing methods of nanocarriers. These drug release and permeation methods are pending to be standardized. Their biorelevance with reference to in vivo plasma concentration–time profiles requires further exploration to enable translation of in vitro data for in vivo or clinical performance prediction. © 2019, American Association of Pharmaceutical Scientists.
publisher Springer New York LLC
issn 15309932
language English
format Review
accesstype
record_format scopus
collection Scopus
_version_ 1828987875412148224